New Payment Models For Curative Treatments Have CMS’ Attention, Verma Says

 
• By Cathy Kelly
Attention please sign with megaphone - Vector
Concerns over the high cost of Zolgensma prompting 'serious discussions.'

More from Medicare

More from Government Payers